Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
No Relationships to Disclose |
|
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Bayer |
Recipient: Your Institution |
Company: Bristol-Myers Squibb |
Recipient: Your Institution |
Company: Takeda |
Recipient: Your Institution |
Company: Pfizer |
Recipient: Your Institution |
Company: Exelixis |
Recipient: Your Institution |
Company: Amgen |
Recipient: Your Institution |
Company: AstraZeneca |
Recipient: Your Institution |
Company: Calithera Biosciences |
Recipient: Your Institution |
Company: Celldex |
Recipient: Your Institution |
Company: Eisai |
Recipient: Your Institution |
Company: Genentech |
Recipient: Your Institution |
Company: Immunomedics |
Recipient: Your Institution |
Company: Janssen |
Recipient: Your Institution |
Company: Merck |
Recipient: Your Institution |
Company: Lilly |
Recipient: Your Institution |
Company: Nektar |
Recipient: Your Institution |
Company: ORIC Pharmaceuticals |
Recipient: Your Institution |
Company: ORIC Pharmaceuticals |
Recipient: Your Institution |
Company: crispr therapeutics |
Recipient: Your Institution |
Company: Arvinas |
Recipient: Your Institution |
Company: Gilead Sciences |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: Pfizer |
Recipient: You |
Company: Exelixis |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|